Alfred Altomari, Director at Baudax Bio, Inc. (BXRX), bought 5,000 shares at $1.06 ($5K) on 2020-11-23, disclosed to the SEC on 2020-11-24.
Open-market purchase of $5k BXRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| AGRX | BUY | 2021-05-19 | $32K | — | Filing → |
| AGRX | BUY | 2021-03-23 | $25K | — | Filing → |
| INSM | SELL | 2020-12-09 | $791K | — | Filing → |